Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for prevention of peptic ulcers in patients on low-dose aspirin
2006-005073-22Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esomeprazole in gastroduodenal ulcer, gastric ulcer and duodenal ulcer (3 arms), sponsored by AstraZeneca. Primary endpoint: Development of a gastric and/or a duodenal ulcer. Started Nov 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroduodenal ulcergastric ulcerduodenal ulcer
Beyond the preview
Go deeper on 2006-005073-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005073-22.